CLDN8 Antikörper (Middle Region)
Kurzübersicht für CLDN8 Antikörper (Middle Region) (ABIN951553)
Target
Alle CLDN8 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 146-175, Middle Region
-
Spezifität
- This antibody reacts to CLDN8.
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human.
-
Aufreinigung
- Affinity chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 146~175 amino acids from the Center region of human CLDN8
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS, 0.09 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- CLDN8 (Claudin 8 (CLDN8))
-
Andere Bezeichnung
- Claudin-8 / CLDN8
-
Hintergrund
- CLDN8 is components of epithelial cell tight junctions. Tight junctions regulate movement of solutes and ions through the paracellular space and prevent mixing of proteins and lipids in the outer leaflet of the apical and basolateral plasma membrane domains.Synonyms: PRO1573, UNQ779
-
Molekulargewicht
- 24845 Da
-
Gen-ID
- 9073
-
NCBI Accession
- NP_955360
-
Pathways
- Hepatitis C
Target
-